Description:

IMRN is the ticker symbol for Imprimis Pharmaceuticals, Inc., a company listed on the New York Stock Exchange. Imprimis Pharmaceuticals specializes in the compounding of pharmaceuticals, focusing on personalized medications that address unmet patient needs. The company's innovative approach includes providing cost-effective alternatives to branded drugs through its proprietary formulations and custom-compounded medications, which are dispensed by licensed pharmacies. This business model positions Imprimis as a significant player in the healthcare sector, catering to both patients and healthcare providers seeking more affordable and tailored treatment options.

Data:

Yields: